Lijing Ouyang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lijing Ouyang has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Scott Dennis Grosse
Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN, USA
3 shared publications - James William Hardin
University of South Carolina, Columbia, SC
2 shared publications - Joshua R. Mann
University of South Carolina, School of Medicine, Department of Family and Preventive Medicine, 3209 Colonial Drive, Columbia, SC 29203, United States
2 shared publications Likang Xu
National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA
2 shared publications- Orgul Demet Ozturk
University of South Carolina
2 shared publications Shanna Cox
Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA
2 shared publications
Latest Publications
- 3 April 2023
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 247, 109864
Mental health and substance use disorders at delivery hospitalization and readmissions after delivery discharge
- 3 April 2023
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 247, 109864
Mental health and substance use disorders at delivery hospitalization and readmissions after delivery discharge
- 5 January 2022
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 139 (2) , 235-243
Variations in Low-Risk Cesarean Delivery Rates in the United States Using the Society for Maternal-Fetal Medicine Definition
OBJECTIVE: To assess variations in low-risk cesarean delivery rates in the United States using the Society for Maternal-Fetal Medicine (SMFM) definition of low-risk for cesarean delivery and to identify factors associated with low-risk cesarean deliveries. METHODS: From hospital discharge data in the 2018 National Inpatient Sample and State Inpatient Databases, we identified deliveries that were low-risk for cesarean delivery using the SMFM definition based on the International Classification of Diseases, Tenth Revision, Clinical Modification codes. We estimated national low-risk cesarean delivery rates overall and by patient characteristics, clinically relevant conditions not included in the SMFM definition, and hospital characteristics based on the nationally representative sample of hospital discharges in the National Inpatient Sample. Multivariate logistic regressions were estimated for the national sample to identify factors associated with low-risk cesarean delivery. We reported low-risk cesarean delivery rates for 27 states and the District of Columbia based on the annual state data that represented the universe of hospital discharges from participating states in the State Inpatient Databases. RESULTS: Of an estimated 3,634,724 deliveries in the 2018 National Inpatient Sample, 2,484,874 low-risk deliveries met inclusion criteria. The national low-risk cesarean delivery rate in 2018 was 14.6% (95% CI 14.4–14.8%). The rates varied widely by state (range 8.9–18.6%). Nationally, maternal age older than 40 years, non-Hispanic Black or Asian race, private insurance as primary payer, admission on weekday, obesity, diabetes, or hypertension, large metropolitan residence, and hospitals of the South census region were associated with low-risk cesarean delivery. CONCLUSION: Approximately one in seven low-risk deliveries was by cesarean in 2018 in the United States using the SMFM definition and the low-risk cesarean delivery rates varied widely by state.
- 5 January 2022
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 139 (2) , 235-243
Variations in Low-Risk Cesarean Delivery Rates in the United States Using the Society for Maternal-Fetal Medicine Definition
OBJECTIVE: To assess variations in low-risk cesarean delivery rates in the United States using the Society for Maternal-Fetal Medicine (SMFM) definition of low-risk for cesarean delivery and to identify factors associated with low-risk cesarean deliveries. METHODS: From hospital discharge data in the 2018 National Inpatient Sample and State Inpatient Databases, we identified deliveries that were low-risk for cesarean delivery using the SMFM definition based on the International Classification of Diseases, Tenth Revision, Clinical Modification codes. We estimated national low-risk cesarean delivery rates overall and by patient characteristics, clinically relevant conditions not included in the SMFM definition, and hospital characteristics based on the nationally representative sample of hospital discharges in the National Inpatient Sample. Multivariate logistic regressions were estimated for the national sample to identify factors associated with low-risk cesarean delivery. We reported low-risk cesarean delivery rates for 27 states and the District of Columbia based on the annual state data that represented the universe of hospital discharges from participating states in the State Inpatient Databases. RESULTS: Of an estimated 3,634,724 deliveries in the 2018 National Inpatient Sample, 2,484,874 low-risk deliveries met inclusion criteria. The national low-risk cesarean delivery rate in 2018 was 14.6% (95% CI 14.4–14.8%). The rates varied widely by state (range 8.9–18.6%). Nationally, maternal age older than 40 years, non-Hispanic Black or Asian race, private insurance as primary payer, admission on weekday, obesity, diabetes, or hypertension, large metropolitan residence, and hospitals of the South census region were associated with low-risk cesarean delivery. CONCLUSION: Approximately one in seven low-risk deliveries was by cesarean in 2018 in the United States using the SMFM definition and the low-risk cesarean delivery rates varied widely by state.
- 1 August 2019
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 100 (8) , 1475-1481
Differences in Length of Stay and Costs Between Comparable Hospitalizations of Patients With Spina Bifida With or Without Pressure Injuries
- 1 August 2019
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 100 (8) , 1475-1481
Differences in Length of Stay and Costs Between Comparable Hospitalizations of Patients With Spina Bifida With or Without Pressure Injuries
- Open Access
- 17 July 2014
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 29 (S3) , 732-738
Use of State Administrative Data Sources to Study Adolescents and Young Adults with Rare Conditions
Effective care of young people with rare conditions requires ongoing coordinated medical treatment as well as educational and social support services. However, information on treatment is often lacking due to limited data. South Carolina has a repository of comprehensive health and human service data with which individuals may be tracked across the data systems of multiple state agencies and organizations.
- 17 July 2014
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 29 (S3) , 732-738
Open AccessUse of State Administrative Data Sources to Study Adolescents and Young Adults with Rare Conditions
Effective care of young people with rare conditions requires ongoing coordinated medical treatment as well as educational and social support services. However, information on treatment is often lacking due to limited data. South Carolina has a repository of comprehensive health and human service data with which individuals may be tracked across the data systems of multiple state agencies and organizations.
- 26 August 2010
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 54 (10) , 918-928
Employment impact and financial burden for families of children with fragile X syndrome: findings from the National Fragile X Survey
The employment impact and financial burden experienced by families of children with fragile X syndrome (FXS) has not been quantified in the USA. Using a national fragile X family survey, we analysed data on 1019 families with at least one child who had a full FXS mutation. Out-of-pocket expenditures related to fragile X were reported. We used logistic regression to examine the role of insurance, number of affected children, and number of total co-occurring conditions in predicting the financial burden and employment impact of FXS, while adjusting for race, education, marital status and other sociodemographic predictors. Almost half of families affected by FXS reported that they had experienced an increased financial burden and nearly 60% stated that they had had to change work hours or stop work because of FXS. Families with health insurance that met family needs were significantly less likely to report an excess financial burden. The type of insurance (private or public) was not associated with the reported financial burden. Affected children's mutation status, especially male children with the full mutation, was associated with employment impact. The total number of co-occurring conditions was associated with both financial burden and employment impact. Families affected by FXS experienced a significant employment impact and financial burden. Policies designed to help families with FXS need to take into consideration the dimension of co-occurring conditions.
- 26 August 2010
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 54 (10) , 918-928
Employment impact and financial burden for families of children with fragile X syndrome: findings from the National Fragile X Survey
The employment impact and financial burden experienced by families of children with fragile X syndrome (FXS) has not been quantified in the USA. Using a national fragile X family survey, we analysed data on 1019 families with at least one child who had a full FXS mutation. Out-of-pocket expenditures related to fragile X were reported. We used logistic regression to examine the role of insurance, number of affected children, and number of total co-occurring conditions in predicting the financial burden and employment impact of FXS, while adjusting for race, education, marital status and other sociodemographic predictors. Almost half of families affected by FXS reported that they had experienced an increased financial burden and nearly 60% stated that they had had to change work hours or stop work because of FXS. Families with health insurance that met family needs were significantly less likely to report an excess financial burden. The type of insurance (private or public) was not associated with the reported financial burden. Affected children's mutation status, especially male children with the full mutation, was associated with employment impact. The total number of co-occurring conditions was associated with both financial burden and employment impact. Families affected by FXS experienced a significant employment impact and financial burden. Policies designed to help families with FXS need to take into consideration the dimension of co-occurring conditions.
- Open Access
- 15 February 2010
- Published by Springer Nature in BMC Pediatrics
- Vol. 10 (1) , 9
Discontinuation of thyroid hormone treatment among children in the United States with congenital hypothyroidism: findings from health insurance claims data
Thyroid hormone treatment in children with congenital hypothyroidism can prevent intellectual disability. Guidelines recommend that children diagnosed with congenital hypothyroidism through newborn screening remain on treatment to at least 3 years of age, after which a trial off therapy can determine which children have transient hypothyroidism. The purpose of this study was to describe the rate at which children with congenital hypothyroidism in the United States discontinue thyroid hormone treatment in early childhood.
- 15 February 2010
- Published by Springer Nature in BMC Pediatrics
- Vol. 10 (1) , 9
Open AccessDiscontinuation of thyroid hormone treatment among children in the United States with congenital hypothyroidism: findings from health insurance claims data
Thyroid hormone treatment in children with congenital hypothyroidism can prevent intellectual disability. Guidelines recommend that children diagnosed with congenital hypothyroidism through newborn screening remain on treatment to at least 3 years of age, after which a trial off therapy can determine which children have transient hypothyroidism. The purpose of this study was to describe the rate at which children with congenital hypothyroidism in the United States discontinue thyroid hormone treatment in early childhood.
- 2 March 2007
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 79 (7) , 552-558
Health care expenditures of children and adults with spina bifida in a privately insured U.S. population
BACKGROUND: We provide new estimates of medical care utilization and expenditures over the lifespan for persons living with spina bifida in the United States. Updated estimates are essential for calculations of lifetime costs and for economic evaluations of prevention and management strategies for spina bifida.METHODS: We analyzed data from the 2001–2003 MarketScan database on paid medical and prescription drug claims of persons covered by employer‐sponsored health insurance in the United States. Medical care utilization and expenditures during 2003 were analyzed for persons with a diagnosis of spina bifida recorded during 2001–2003 who had 12 months of coverage in a fee‐for‐service health plan. To calculate expenditures during infancy, a separate analysis was performed for those born during 2002 with claims and expenditures data during the first 12 months of life. We compared medical expenditures for persons with and without spina bifida by age groups.RESULTS: Average incremental medical expenditures comparing patients with spina bifida and those without were $41,460 per year at age 0, $14,070 at ages 1–17, $13,339 at ages 18–44, and $10,134 at ages 45–64. Children ages 1–17 years with spina bifida had average medical expenditures 13 times greater than children without spina bifida. Adults with spina bifida had average medical expenditures three to six times greater than adults without spina bifida in this privately insured population.CONCLUSIONS: Although per capita medical care utilization and expenditures are highest among children, adults constitute an important and growing share of the population living with spina bifida. Birth Defects Research (Part A) 2007.
- 2 March 2007
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 79 (7) , 552-558
Health care expenditures of children and adults with spina bifida in a privately insured U.S. population
BACKGROUND: We provide new estimates of medical care utilization and expenditures over the lifespan for persons living with spina bifida in the United States. Updated estimates are essential for calculations of lifetime costs and for economic evaluations of prevention and management strategies for spina bifida.METHODS: We analyzed data from the 2001–2003 MarketScan database on paid medical and prescription drug claims of persons covered by employer‐sponsored health insurance in the United States. Medical care utilization and expenditures during 2003 were analyzed for persons with a diagnosis of spina bifida recorded during 2001–2003 who had 12 months of coverage in a fee‐for‐service health plan. To calculate expenditures during infancy, a separate analysis was performed for those born during 2002 with claims and expenditures data during the first 12 months of life. We compared medical expenditures for persons with and without spina bifida by age groups.RESULTS: Average incremental medical expenditures comparing patients with spina bifida and those without were $41,460 per year at age 0, $14,070 at ages 1–17, $13,339 at ages 18–44, and $10,134 at ages 45–64. Children ages 1–17 years with spina bifida had average medical expenditures 13 times greater than children without spina bifida. Adults with spina bifida had average medical expenditures three to six times greater than adults without spina bifida in this privately insured population.CONCLUSIONS: Although per capita medical care utilization and expenditures are highest among children, adults constitute an important and growing share of the population living with spina bifida. Birth Defects Research (Part A) 2007.